What Are Sell-Side Analysts? Ratings, Conflicts, and Rules

Sell-side analysts are research professionals at brokerage firms and investment banks who study publicly traded companies and publish their findings for investors to use. They cover a defined slate of companies in a single industry, build financial models, issue ratings like Buy or Sell, and set 12-month price targets. Their reports flow out to institutional clients like pension funds and hedge funds, and often reach individual investors through brokerage accounts and the financial press. Knowing what they do, who pays them, and where their incentives pull is the difference between using their work well and taking a headline rating at face value.

What the Job Actually Involves

Each analyst covers a defined group of companies, usually within one industry such as semiconductors, pharmaceuticals, or consumer retail. The core of the work is a detailed financial model that projects revenue, earnings, and cash flow for every company in the coverage universe. Those models get updated constantly from SEC filings (annual 10-K reports and quarterly 10-Q updates), earnings calls, industry conferences, and direct conversations with company management.

Engagement with corporate leadership is a bigger part of the job than outsiders realize. Analysts join quarterly earnings calls and press management on revenue guidance, margin trends, and capital spending. The better ones push back on rosy projections and test management’s claims against what competitors and suppliers are reporting. When a report lands, it is supposed to reflect the analyst’s own judgment, not a repackaged version of the company’s investor deck.

Experienced analysts also perform what the industry calls channel checks: gathering intelligence from a company’s suppliers, distributors, and customers. If a smartphone maker claims strong demand for a new product, a good analyst will call component suppliers and retail partners to see whether order volumes match the story. That ground-level verification is time-intensive and depends on a deep network of industry contacts, but it is often where problems get caught before they show up in the financials.

How Individual Estimates Become the Consensus

When a company reports quarterly earnings, the headline almost always frames results as a beat or miss against the consensus estimate. That consensus starts with individual sell-side analysts, each publishing their own projection for earnings per share, revenue, and other key metrics. Data providers like Bloomberg, FactSet, and LSEG collect those estimates and calculate an average or median, which becomes the consensus number markets trade around.

The consensus is usually published alongside the range of estimates and the number of analysts contributing. When actual results deviate, stock prices move, sometimes sharply. A wide beat typically sends a stock up; a miss triggers a selloff. This is why sell-side estimates carry real market power even though they are ultimately educated guesses. If a stock drops 8% on record revenue, the answer is almost always that the revenue fell short of what analysts expected.

Sell-Side vs. Buy-Side

The distinction shapes everything about how each type of analyst works. Sell-side analysts work at brokerage firms and investment banks, producing research that gets distributed to outside clients. Their output is public-facing: written reports, ratings, price targets, and media appearances. The goal is to generate ideas that attract trading commissions or justify research subscription fees.

Buy-side analysts work for the firms that actually invest capital: mutual funds, hedge funds, pension funds, and insurance companies. Their research stays internal. A buy-side analyst at a mutual fund isn’t publishing for the world; they’re advising their own portfolio managers on what to buy or sell. They consume plenty of sell-side research, but layer their own analysis on top and often reach different conclusions.

The incentive structures diverge. A sell-side analyst’s career depends partly on client relationships and visibility; bold, well-argued calls that institutional clients find useful keep the phone ringing. A buy-side analyst’s performance is judged more directly on investment returns. Neither system is perfectly aligned with your interests as an individual investor, but knowing which side produced a piece of research helps you calibrate how much weight to give it.

Where Sell-Side Analysts Work

Large investment banks like Goldman Sachs, Morgan Stanley, and JPMorgan maintain some of the biggest research departments. These banks use research to support their institutional sales and trading desks. When a pension fund routes a large trade through a bank’s desk, the quality of that bank’s research is often part of why the client chose it. Research drives trading volume, and trading volume drives revenue.

Independent research firms operate outside the investment banking ecosystem, which in theory frees them from certain conflicts. These boutique shops often specialize in specific sectors where they can develop deeper expertise than a generalist bank analyst covering 30 companies. Some commercial banks with retail brokerage arms also employ analysts to serve individual investors managing personal retirement or brokerage accounts.

What the Ratings and Price Targets Mean

Most research reports boil down to a headline rating, but the terminology varies. Some firms use absolute labels: Buy, Hold, Sell. Others use relative ones: Overweight, Equal Weight, Underweight. The difference isn’t just cosmetic. An Overweight rating means the analyst expects the stock to outperform others in its sector or a benchmark index like the S&P 500. A Buy rating is typically an absolute call that the stock price will rise.

The rating is almost always paired with a 12-month price target, a specific dollar figure representing where the analyst believes the stock will trade in a year.1Cboe Global Markets. Analyst Price Target and Retail Option Trading Targets come out of the valuation work in the report and give investors a concrete benchmark for upside or downside. If a stock trades at $50 and an analyst sets a $65 price target with a Buy rating, they’re projecting 30% upside over the next year.

Price targets vary widely across analysts covering the same stock because the underlying models rest on judgment calls: what revenue growth to assume, how margins will move, what discount rate to apply. Two competent analysts can plug different assumptions into the same framework and land on price targets that differ by 30% or more. A wide spread between the highest and lowest targets on a stock is genuine disagreement about those inputs, not sloppiness.

The Buy-Rating Skew

Here is something worth knowing before you trust any rating: sell-side calls have historically been overwhelmingly positive. Academic research covering the late 1990s through the early 2000s found that Buy recommendations routinely made up 60% to 74% of all outstanding ratings, while Sell recommendations barely reached 2% to 4%. The imbalance softened after regulatory reforms in 2002 and 2003, but the structural incentive hasn’t gone away. Analysts who publish Sell ratings risk damaging relationships with the companies they cover, which can mean losing access to management, getting cut out of earnings calls, and ultimately hurting their ability to do the job.

None of this makes sell-side research useless. The detailed financial models, industry analysis, and management access in a good report have real value even if you ignore the headline rating entirely. Many experienced investors read the report for the data and reach their own conclusions on whether to buy or sell.

Conflicts of Interest and the Rules That Police Them

The biggest conflict in sell-side research has always been the relationship between analysts and their firm’s investment banking division. Investment banks earn large fees from underwriting stock offerings, advising on mergers, and arranging debt financing. A negative report on a company that is also an investment banking client creates an obvious problem. In the late 1990s, some firms let this conflict run unchecked, and the consequences eventually landed on the front page.

The 2003 Global Settlement

In 2003, ten of the largest investment firms agreed to pay $1.4 billion to settle charges that their research had been tainted by investment banking conflicts. The settlement included $387.5 million in restitution for harmed investors and $487.5 million in penalties, with additional funds earmarked for independent research and investor education.2FINRA.org. 2003 Global Settlement The firms also agreed to structural reforms designed to prevent research from being used as a tool to win banking business.

FINRA Rule 2241 and Regulation AC

Today, FINRA Rule 2241 codifies the separation between research and investment banking at brokerage firms. The rule requires firms to maintain written policies that prohibit analyst compensation from being based on specific investment banking transactions. An analyst’s pay must be reviewed annually by a committee with no investment banking representation, and that committee must consider whether the analyst’s past recommendations actually correlated with stock performance. Firms must disclose in each research report whether the analyst’s compensation was tied to investment banking revenue, and they are flatly prohibited from promising favorable research as an inducement for business.3FINRA.org. FINRA Rule 2241 – Research Analysts and Research Reports

Separately, SEC Regulation AC requires every research report to include a signed statement from the analyst attesting that the views expressed reflect their personal opinions. The analyst must also certify either that their compensation is not tied to their specific recommendations, or, if it is, disclose the source, amount, and purpose of that compensation along with a warning that it could influence the report’s conclusions. These certifications also apply to public appearances: analysts must attest quarterly that their televised or conference comments reflected their genuine views at the time.4eCFR. Regulation AC—Analyst Certification

These rules have meaningfully improved the landscape compared to the late 1990s. The underlying tension has not been eliminated. An analyst who consistently publishes bearish research on companies that might otherwise hire the firm’s bankers will always face some degree of institutional friction, even if no one explicitly pressures them to change a rating.

How Research Gets Paid For, and Why Coverage Is Shrinking

The funding model for sell-side research has changed dramatically over the past decade. Traditionally, research was bundled with trade execution through what the industry calls soft dollar arrangements. When an institutional client executed a trade through a brokerage firm, a portion of the commission went toward paying for the firm’s research. The client got research without writing a separate check, and the brokerage firm got trading volume. Section 28(e) of the Securities Exchange Act of 1934 created a safe harbor for this arrangement, protecting money managers who pay higher commissions in exchange for research services as long as they determine in good faith that the total commission is reasonable relative to the value received.5SEC.gov. Interpretive Release Concerning the Scope of Section 28(e) of the Securities Exchange Act of 1934

The EU’s Markets in Financial Instruments Directive II (MiFID II), which took effect in January 2018, upended that model for any firm doing business with European clients. MiFID II requires asset managers to pay for research separately from execution, either out of the firm’s own pocket or through a dedicated research payment account funded by clients. Bundling research into trading commissions is no longer permitted in the EU.

The ripple effects reached U.S. firms immediately. The SEC issued no-action relief in 2017 allowing American broker-dealers to accept direct research payments from European clients without triggering registration as investment advisers under U.S. law.6SEC.gov. No-Action Letter: Securities Industry and Financial Markets Association The broader consequence has been a significant compression in research spending. Industry estimates suggest the research portion of commission budgets dropped by roughly 40% in the years following MiFID II, and many buy-side firms cut the number of research providers they use. A large asset manager that once subscribed to 200 research providers might now work with 150 or fewer.

The practical effect for investors is that fewer companies, particularly smaller ones, get regular analyst coverage. Global research on coverage found that per-firm analyst following fell about 18% from its 2012 peak through 2021, with the steepest declines among small-cap companies in the EU, where coverage dropped nearly 29%. The growth of passive index investing has compounded the problem: when more capital flows into index funds that don’t rely on stock-picking research, the economic case for producing that research weakens further.

Reading a Report With Clear Eyes

Sell-side reports are most useful when you treat them as structured data rather than investment instructions. The financial model, the industry analysis, the management commentary, and the peer comparisons save you an enormous amount of time. The headline rating and price target are where conflicts, career incentives, and institutional pressures have the most room to distort the picture.

Pay attention to the disclosures. Regulation AC certifications and FINRA-mandated conflict disclosures appear in the fine print of every report, and they will tell you whether the analyst’s firm has an investment banking relationship with the company, whether the firm owns the stock, and whether the analyst’s pay is linked to the recommendation. Most people skip that section. Don’t.